Bridelia atroviridis Müll. Arg. (B. atroviridis) is a plant used in Cameroonian traditional medicine to manage diabetes. The effects of hydroethanolic barks extract from B. atroviridis were evaluated on diabetes disorders including hematology, inflammatory, and oxidative stress parameters. The in vitro antioxidant capacity of the hydroethanolic bark extract (70 : 30) was evaluated. Nicotinamide-/streptozotocin-induced diabetic rats were daily treated with the B. atroviridis extract for fifteen days. Glycemia were evaluated every 5 days, insulin sensibility test was performed, and haematological, inflammatory, and oxidative stress parameters were analysed. Histomorphometry of the pancreas was realized. The extract was able to scavenge free radicals in vitro and decrease significantly the blood glucose levels. The treatment resulted in a significant alleviation of insulin resistance, anemia, leukocytopenia, and thrombocytopenia observed in untreated diabetic rats. The extract significantly decreased proinflammatory cytokines TNF-α, IL-1β, and IL-10. The rate of reduced glutathione was increased in the pancreas, whereas the catalase activity and nitrite concentration were decreased. Diabetic control showed a reduced size of Langerhans islet, whereas the size of islets was large in treated groups. The hydroethanolic extract of B. atroviridis was able to improve glycemia and alleviate haematological and inflammatory parameters disorders observed in diabetic conditions, probably due to its antidiabetic, anti-inflammatory, and antioxidant capacities.
Background: Bone fracture is a condition in which there is a break in the continuity of the bone due to traumatic or pathological factors. Fracture management includes orthopedic, surgical, non-surgical techniques and drug treatments. However, these treatments possess a limitation. Facilitating bone healing process reduce the cost, the time of treatment and is also beneficial for a quick recovery of the patient. The present study aimed to investigate the effect of the mixture aqueous extracts from Oxalis corniculata and Acmella caulirhiza on the bone formation.
Methodology: Wistar female rats were fractured using a drill machine by inserting a drill bit in the femur diaphysis. Fractured animals were subdivided into five groups. One group receiving palm oil, four groups receiving the mixture of plant extracts at the doses of 150, 300, 600 mg/kg or diclofenac at the dose of 357 mg/kg. Substances were given via percutaneous and oral routes for two weeks. At the end of the experimental period, bones were collected and homogenized for the evaluation of the following biochemical parameters: alkaline phosphatase (ALP); reduced glutathione (GSH), nitrites, superoxide dismutase (SOD), interleukin-1β and interleukin-6. Moreover, histomorphometry of the bone at the fracture site was realized.
Results: Percutaneous treatment with the plant extracts resulted in a significant increase of ALP activity (p<0.05) in fractured rats as compared to the control. The mixture extracts also alleviated the fracture-induced oxidative stress by increasing the concentrations of GSH and nitrites; SOD and catalase activities. Furthermore, the plant extracts improved deregulated cytokines observed in fractured bone. Histopathological examination showed a more pack-like structure with a significant decrease in trabeculae number, trabecular interspace with the increase in the bone thickness.
Conclusion: The mixture aqueous extracts from Oxalis corniculata and Acmella caulirhiza possesses bone healing effect due to its ability to alleviate oxidative stress, regulate pro-inflammatory cytokines and improve the structure of the new bone formed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.